Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Feb;107(3):241-6.
doi: 10.1172/JCI11991.

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB

A S Baldwin  1
Affiliations
Review

Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB

A S Baldwin. J Clin Invest. 2001 Feb.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Induction of NF-κB by TNF or other stimuli leads to the transcriptional activation of genes that suppress apoptosis. The proteins encoded by the genes function at different levels in the caspase cascade to block apoptosis.
Figure 2
Figure 2
Roles of NF-κB in oncogenesis and in cancer chemo- and radioresistance. Activation of NF-κB blocks apoptosis, induces cell proliferation, potentially blocks differentiation, and promotes metastasis.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ghosh S, May M, Kopp E. NF-κB and Rel proteins: evolutionarily conserved mediators of immune respones. Annu Rev Immunol. 1998; 16:225–260. - PubMed
    1. Zandi E, Karin M. Bridging the gap: composition, regulation, and physiological function of the IκB kinase complex. Mol Cell Biol. 1999; 19:4547–4551. - PMC - PubMed
    1. Zhong H, Voll R, Ghosh S. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the co-activator CBP/p300. Mol Cell. 1998; 1:661–671. - PubMed
    1. Gilmore T, Koedood M, Piffat K, White D. Rel/NF-κB/IκB proteins and cancer. Oncogene. 1996; 13:1367–1378. - PubMed
    1. Rayet B, Gelinas C. Aberrant Rel/NF-κB genes and activity in human cancer. Oncogene. 1999; 18:6938–6947. - PubMed

Publication types